Clinical Trials in North Carolina

Showing 12221-12240 of 20,428 trials

Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris

NCT02616614

Actavis has developed a generic formulation of clindamycin 1.2% and benzoyl peroxide 3.75% gel. This study is designed to evaluate the safety and efficacy of this formulation in subjects with Acne Vulgaris

Acne Vulgaris

Actavis Inc.862 participantsStarted May 2015

Phoenix, Arizona, United States • Chula Vista, California, United States • La Mesa, California, United States +14 more locations

COMPLETEDPhase 341 miles

A Study to Evaluate the Safety and Clinical Study of Azelaic Acid Gel 15% in Patients With Moderate Facial Rosacea

NCT02120924

The purpose of the study is to compare the safety and efficacy profiles of a generic Azelaic Acid Gel, 15% to the reference listed Finacea® (azelaic acid) Gel, 15% in the treatment of moderate facial rosacea.

Rosacea

Actavis Inc.1,009 participantsStarted Jul 2013

Fremont, California, United States • Santa Monica, California, United States • Brandon, Florida, United States +27 more locations

Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris

A Study to Evaluate the Safety and Clinical Study of Azelaic Acid Gel 15% in Patients With Moderate Facial Rosacea

Find Trials by Condition in North Carolina

Study of Dupilumab (REGN668/SAR231893) Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis

Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer

Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer

Immunotherapy Study for Surgically Resected Pancreatic Cancer

CRLX101(NLG207) in Combination With Bevacizumab for Metastatic Renal Cell Carcinoma (mRCC) Versus Standard of Care (SOC)

VAL-1221 Delivered Intravenously in Ambulatory and Ventilator-free Participants With Late-Onset Pompe Disease

Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

Evaluation of the Pharmacokinetics (PK) and Pharmacodymamics (PD) of Ganciclovir (GCV) in Premature Infants Receiving Treatment for Cytomegalorivus (CMV) Infection

Transvenous Lead Removal Post-Market Clinical Study

A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)

A Study to Assess the Safety and the Efficacy of IV Fosnetupitant/Palonosetron (260 mg/0.25 mg) Combination Compared to Oral Netupitant/Palonosetron (300 mg/0.5 mg) Combination for the Prevention of CINV in AC Chemotherapy in Women With Breast Cancer

Safety Study of ECO Conversion System For Red Blood Cells.

Dupilumab As An Adjunct For Subcutaneous Grass Immunotherapy

Vaccine Study for Surgically Resected Pancreatic Cancer

A Phase 1b Open Label, Dose Escalation Study of PLX3397 in Combination With Vemurafenib in V600-mutated BRAF Melanoma

ENABLE: CHF-PC (Comprehensive Heartcare For Patients and Caregivers)

Non-invasive Buttock Lifting Induced by Magnetic Device - Multicentric Study

A Study of LY3295668 Erbumine in Participants With Breast Cancer That Has Spread to Other Parts of the Body